Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations

Authors: Q An, L Jones, W Tapper, C Chelala, M Iravani, A MacKay, V Hammond, L Durcan, S Gerty, A Ferguson, J Strefford, S Peock, J Reis-Filho, D Easton, A Ashworth, D Eccles

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

To develop a sensitive and specific pathology-based predictor to improve identification of BRCA1 and BRCA2 gene carriers. …
Metadata
Title
A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations
Authors
Q An
L Jones
W Tapper
C Chelala
M Iravani
A MacKay
V Hammond
L Durcan
S Gerty
A Ferguson
J Strefford
S Peock
J Reis-Filho
D Easton
A Ashworth
D Eccles
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2528

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Poster presentation

Regulation of the apoptotic genes in breast cancer cells by the transcription factor CTCF

Poster presentation

Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy

Poster presentation

PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival

Poster presentation

Modelling breast cancer in a three-dimensional heterotypic culture system

Poster presentation

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy

Poster presentation

Loss of CSMD1 disrupts mammary epithelial morphogenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits